These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26292865)

  • 41. Management of overactive bladder syndrome.
    Srikrishna S; Robinson D; Cardozo L; Vella M
    Postgrad Med J; 2007 Jul; 83(981):481-6. PubMed ID: 17621619
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Re: Botulinum A toxin as a treatment for overactive rectum with associated faecal incontinence.
    Hotouras A; Chan CL
    Colorectal Dis; 2012 Jul; 14(7):898-9. PubMed ID: 22564854
    [No Abstract]   [Full Text] [Related]  

  • 43. Development of de novo urge incontinence in women post sling: the role of preoperative urodynamics in assessing the risk.
    Alperin M; Abrahams-Gessel S; Wakamatsu MM
    Neurourol Urodyn; 2008; 27(5):407-11. PubMed ID: 17985373
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effectiveness of botulinum toxin injection in the treatment of de novo OAB symptoms following midurethral sling surgery.
    Miotla P; Futyma K; Cartwright R; Bogusiewicz M; Skorupska K; Markut-Miotla E; Rechberger T
    Int Urogynecol J; 2016 Mar; 27(3):393-8. PubMed ID: 26364180
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The changing face of urinary continence surgery in England: a perspective from the Hospital Episode Statistics database.
    Withington J; Hirji S; Sahai A
    BJU Int; 2014 Aug; 114(2):268-77. PubMed ID: 24512557
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combined behavioral and individualized drug therapy versus individualized drug therapy alone for urge urinary incontinence in women.
    Burgio KL; Goode PS; Richter HE; Markland AD; Johnson TM; Redden DT
    J Urol; 2010 Aug; 184(2):598-603. PubMed ID: 20639023
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Nerve growth factor as a biomarker in the diagnosis and treatment of overactive bladder (OAB)].
    Jankiewicz K; Kulik-Rechberger B; Nowakowski Ł; Rechberger T
    Ginekol Pol; 2012 Jul; 83(7):532-6. PubMed ID: 22880479
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Botulinum toxin a versus placebo for refractory detrusor overactivity in women: a randomised blinded placebo-controlled trial of 240 women (the RELAX study).
    Tincello DG; Kenyon S; Abrams KR; Mayne C; Toozs-Hobson P; Taylor D; Slack M
    Eur Urol; 2012 Sep; 62(3):507-14. PubMed ID: 22236796
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New evidence in the treatment of overactive bladder.
    Brown ET; Martin L; Dmochowski RR
    Curr Opin Obstet Gynecol; 2015 Oct; 27(5):366-72. PubMed ID: 26308197
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New therapies in the treatment of overactive bladder.
    Yeo EK; Hashim H; Abrams P
    Expert Opin Emerg Drugs; 2013 Sep; 18(3):319-37. PubMed ID: 23885696
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Solifenacin in women with de novo overactive bladder after tension-free obturator vaginal tape--is it effective?
    Serati M; Braga A; Sorice P; Siesto G; Salvatore S; Ghezzi F
    J Urol; 2014 May; 191(5):1322-6. PubMed ID: 24148761
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urinary urgency - translating the evidence base into daily clinical practice.
    Cardozo L; Chapple CR; Dmochowski R; Fitzgerald MP; Hanno P; Michel MC; Staskin D; Van Kerrebroeck P; Wyndaele JJ; Yamaguchi O; Yoshida M
    Int J Clin Pract; 2009 Dec; 63(12):1675-82. PubMed ID: 19930329
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Headache in 2010: Progress in headache mechanisms and management.
    Lipton RB
    Nat Rev Neurol; 2011 Feb; 7(2):67-8. PubMed ID: 21297646
    [No Abstract]   [Full Text] [Related]  

  • 54. Botulinum toxin A for the Treatment of Overactive Bladder.
    Hsieh PF; Chiu HC; Chen KC; Chang CH; Chou EC
    Toxins (Basel); 2016 Feb; 8(3):. PubMed ID: 26938559
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Re: A group-based yoga therapy intervention for urinary incontinence in women: a pilot randomized trial.
    Wein AJ
    J Urol; 2015 Apr; 193(4):1313. PubMed ID: 25890531
    [No Abstract]   [Full Text] [Related]  

  • 56. Re: botulinum toxin A modulates afferent fibers in neurogenic detrusor overactivity.
    Wein AJ
    J Urol; 2014 May; 191(5):1340-1. PubMed ID: 24745503
    [No Abstract]   [Full Text] [Related]  

  • 57. Botulinum-A Toxin's efficacy in the treatment of idiopathic overactive bladder.
    Moga MA; Banciu S; Dimienescu O; Bigiu NF; Scarneciu I
    J Pak Med Assoc; 2015 Jan; 65(1):76-80. PubMed ID: 25831681
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Editorial comment. Female urology.
    Chapple C
    Curr Opin Urol; 2009 Jul; 19(4):335-6. PubMed ID: 19483499
    [No Abstract]   [Full Text] [Related]  

  • 59. Predictors of persistent detrusor overactivity after transvaginal sling procedures.
    Gamble TL; Botros SM; Beaumont JL; Goldberg RP; Miller JJ; Adeyanju O; Sand PK
    Am J Obstet Gynecol; 2008 Dec; 199(6):696.e1-7. PubMed ID: 18845297
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A pragmatic approach to the characterization and effective treatment of male patients with postprostatectomy incontinence.
    Cornu JN; Melot C; Haab F
    Curr Opin Urol; 2014 Nov; 24(6):566-70. PubMed ID: 25203242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.